Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging
Open Access
- 1 April 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (14), e6534
- https://doi.org/10.1097/md.0000000000006534
Abstract
Demyelination and axonal degeneration caused by multiple sclerosis (MS) exist in the white matter and not only in the lesion area. Magnetic resonance spectroscopy (MRS) could provide a unique insight into metabolic changes in the normal appearing white matter (NAWM). To evaluate the subtle axonal degeneration and delineate the spatial distribution of metabolite abnormalities in the NAWM in patients with MS. A total of 17 clinically definite relapsing-remitting MS (RRMS) patients and 21 healthy controls were enrolled in this study. 2D 1H magnetic resonance spectroscopic imaging (MRSI) performed at 3 Tesla was used to measure metabolite concentrations in the frontal-parietal-occipital NAWM. Ratios of N-acetyl-aspartate (NAA) and choline (Cho) to creatine (Cr) and Cho to NAA were calculated in each voxel. MS patients showed decreased NAA/Cr and increased Cho/NAA ratios in the NAWM compared to healthy controls. In the parietal NAWM, the extent of NAA/Cr decrease was significantly higher than that in the frontal and parietal-occipital NAWM. Decreased NAA in the NAWM would provide useful metabolic information for evaluation of disease progression in MS. The high extent of NAA decrease in the parietal NAWM helps improve the accuracy of the prediction.Keywords
This publication has 46 references indexed in Scilit:
- The neurochemical profile quantified by in vivo 1H NMR spectroscopyNeuroImage, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 TeslaPLOS ONE, 2010
- Myelin water imaging: Implementation and development at 3.0T and comparison to 1.5T measurementsMagnetic Resonance in Medicine, 2009
- Multiple sclerosisThe Lancet, 2008
- Cognitive dysfunction in multiple sclerosis: a review of recent developmentsCurrent Opinion in Neurology, 2003
- Diffusion tensor imaging in early relapsing-remitting multiple sclerosisMultiple Sclerosis Journal, 2001
- Executive function in multiple sclerosis. The role of frontal lobe pathologyBrain, 1997
- Multiple Sclerosis: Basic Concepts and HypothesisMayo Clinic Proceedings, 1989
- Rating neurologic impairment in multiple sclerosisNeurology, 1983